Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment
    • Inventia Healthcare...

    Inventia Healthcare files Rs 450-cr IPO papers with SEBI

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-09-23T10:00:01+05:30  |  Updated On 23 Sept 2018 10:00 AM IST
    Inventia Healthcare files Rs 450-cr IPO papers with SEBI

    NEW DELHI: Inventia Healthcare has filed draft papers with capital markets regulator SEBI to raise an estimated Rs 450 crore through an initial public offering. The IPO comprises fresh issuance of equity shares worth up to Rs 125 crore, besides, an offer of sale up to 31,64,000 scrips by promoters and other shareholders, according to the draft red herring prospectus (DRHP) filed with Sebi.


    In the offer for sale, promoters --- Janak Shah and Maya Shah -- and private equity fund Jacob Balls will sell shares.


    Proceeds of the issue will be used for payment of outstanding borrowings availed by the company and for other general corporate purposes.


    "Our company intends to strengthen its capital base and expects to receive the benefits of a listing of its equity shares on the stock exchanges, including among other things, enhance our visibility and provide liquidity to our shareholders," the firm noted.


    The initial public offer (IPO) is expected to fetch Rs 450 crore, merchant banking sources said. ICICI Securities and Centrum Capital will manage the company’s initial share sale and the equity shares of the firm will be listed on the BSE and NSE.

    BSEcapital markets regulatorCentrum CapitalDraft Red Herring ProspectusDRHPICICIInventiaInventia HealthcareJanak ShahMaya Shahmerchant bankingNSERs 450 croreSEBI
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok